Alpha 2.0
Login Register
» Authors » F Mazzotta

F Mazzotta

Explore the profile of F Mazzotta including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 68
Citations 555
Followers 0
Related Specialties
Infectious Diseases
Microbiology
Dermatology
Top 10 Co-Authors
G Carosi
F Leoncini
M di Pietro
A Lazzarin
E Bonifazi
G Angarano
S Lo Caputo
M Moroni
A dArminio Monforte
A Antinori
Published In
Infection
J Med Virol
J Infect Dis
Clin Exp Dermatol
J Chemother
Affiliations
Soon will be listed here.
Recent Articles
1.
Chilblain-like lesions (COVID-19 toes) have the same impact on family members than psoriasis systemically treated: insights from a case-control study targeting the pediatric population
Damiani G, Finelli R, Kridin K, Pacifico A, Bragazzi N, Malagoli P, et al.
Eur Rev Med Pharmacol Sci . 2023 Jan; 26(3 Suppl):87-93. PMID: 36591876
Objective: COVID-19 toes represent the main dermatological COVID-19 cutaneous manifestation in pediatric patients. Its diagnosis exposes the whole family to social stigma and this aspect was not previously evaluated. Patients...
2.
Skin manifestations of COVID-19 in children: Part 3
Andina D, Belloni-Fortina A, Bodemer C, Bonifazi E, Chiriac A, Colmenero I, et al.
Clin Exp Dermatol . 2020 Nov; 46(3):462-472. PMID: 33207021
The current COVID-19 pandemic is caused by the SARS-CoV-2 coronavirus. The initial recognized symptoms were respiratory, sometimes culminating in severe respiratory distress requiring ventilation, and causing death in a percentage...
3.
Skin manifestations of COVID-19 in children: Part 1
Andina D, Belloni-Fortina A, Bodemer C, Bonifazi E, Chiriac A, Colmenero I, et al.
Clin Exp Dermatol . 2020 Nov; 46(3):444-450. PMID: 33180982
The current COVID-19 pandemic is caused by the SARS-CoV-2 coronavirus. The initial recognized symptoms were respiratory, sometimes culminating in severe respiratory distress requiring ventilation, and causing death in a percentage...
4.
Skin manifestations of COVID-19 in children: Part 2
Andina D, Belloni-Fortina A, Bodemer C, Bonifazi E, Chiriac A, Colmenero I, et al.
Clin Exp Dermatol . 2020 Nov; 46(3):451-461. PMID: 33166429
The current COVID-19 pandemic is caused by the SARS-CoV-2 coronavirus. The initial recognized symptoms were respiratory, sometimes culminating in severe respiratory distress requiring ventilation, and causing death in a percentage...
5.
No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain
Caselli D, Chironna M, Loconsole D, Nigri L, Mazzotta F, Bonamonte D, et al.
Br J Dermatol . 2020 Jul; 183(4):784-785. PMID: 32613638
No abstract available.
6.
Maraviroc 150 mg daily plus lopinavir/ritonavir, a nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimen for HIV-infected naive patients: 48-week final results of VEMAN study
Nozza S, Galli L, Antinori A, Chiappetta S, Mazzotta F, Zaccarelli M, et al.
Clin Microbiol Infect . 2015 Feb; 21(5):510.e1-9. PMID: 25656621
Non-conventional strategies with nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimens in antiretroviral naive human immunodeficiency virus (HIV) -infected patients have been explored in clinical trials. A prospective, open-label, randomized (1:1), multicentre, proof-of-concept...
7.
HBV whole-genome mutation profile in HIV-1/HBV coinfected patients in a long-term follow-up study
Taffon S, Genovese D, Blasi M, Pierotti P, Degli Esposti A, Catone S, et al.
Infection . 2014 Apr; 42(4):675-87. PMID: 24700252
Purpose: Human immunodeficiency virus (HIV-1)-infected patients frequently harbour hepatitis B and C viruses (HBV and HCV, respectively). Possible modifications of the natural history of hepatitis B may occur. The aim...
8.
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group
Svicher V, Alteri C, Montano M, Nori A, DArrigo R, Andreoni M, et al.
Infection . 2013 Oct; 42(1):61-71. PMID: 24146352
Purpose: We have developed a sequencing assay for determining the usage of the genotypic HIV-1 co-receptor using peripheral blood mononuclear cell (PBMC) DNA in virologically suppressed HIV-1 infected patients. Our...
9.
Hepatitis B and immigrants: a SIMIT multicenter cross-sectional study
Fasano M, Saracino A, Carosi G, Mazzotta F, Marino N, Sagnelli E, et al.
Infection . 2012 Dec; 41(1):53-9. PMID: 23264094
Background: The continuing migration of individuals from geographic areas with high/medium endemicity has determined the arrival of new chronic hepatitis B virus (HBV) carriers in Italy. The magnitude of this...
10.
Factors associated with access to antiviral treatment in a multicentre cross-sectional study of patients with chronic hepatitis B in Italy
Antonucci G, Mazzotta F, Puoti M, Angeletti C, Girardi E, Santantonio T, et al.
J Viral Hepat . 2012 Nov; 19(12):881-9. PMID: 23121367
A multicentre cross-sectional survey was performed to provide an accurate picture of patients with chronic hepatitis B (CHB) cared for by Italian Infectious Diseases Centers (IDCs). This analysis describes factors...